SNAr process for preparing benzimidazole compounds

Details for Australian Patent Application No. 2006262375 (hide)

Owner AstraZeneca AB Array Biopharma Inc.

Inventors Leonard, John; Shakya, Sagar; Ford, James Gair; Evans, Matthew Charles; Hache, Bruno P.; Barnett, Bradley R.; Nichols, Paul J.; Demattei, John

Agent Watermark

Pub. Number AU-A-2006262375

PCT Pub. Number WO2007/002092

Priority 60/693,374 23.06.05 US

Filing date 21 June 2006

Wipo publication date 4 January 2007

International Classifications

A61K 31/4164 (2006.01) - 1,3-Diazoles

C07D 235/04 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/002092 Priority application(s): WO2007/002092

27 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006262378-Lower ash lubricating oil with low cold cranking simulator viscosity

2006262369-Suspension culture of human embryonic stem cells